Additionally, adenocarcinoma patients with high PD-L1 expression (≥ 50%) had shorter survival compared to those with low PD-L1 expression (p = 0.0332) but this difference was lost when patients were divided into two groups with or without PD-L1 expression. This evidence concerns the gene CD274 and adenocarcinoma.